“Give Life a Chance”: new research fund for neuroendocrine tumors

June 15, 2015 News BioVox

The University of Hasselt, the Jessa Hospital and the East Limburg Hospital will conduct research on neuroendocrine tumors (NET), a rare and aggressive form of cancer, with help from “Give Life a Chance”. The research project is an initiative of NET patient Jan Van Manshoven. He founded “Give Life a Chance” to obtain funds for this research. The organization offered a symbolic check of 15.000 euros to the research institutes.

Every year, an average of 300 patients in Belgium are told that they are suffering from neuroendocrine tumors. This rare form of cancer grows rapidly and can result in metastases in the entire body. It was the wish of Jan Van Manshoven -who died from the disease in February 2015- to get more insight into these type of tumors. He founded “Give Life a Chance” to raise funds for scientific research. The research team -which consists of doctors-professors of the three partners- will focus initially on accelerating the diagnosis.

Avatar photo

With a local focus and global reach, the news platform BioVox shares insights into the Benelux life sciences ecosystem with readers across the world. BioVox is an independent publisher, providing its community with quality content and first-row access to interesting breakthroughs and trends in biotech, medtech, agtech, pharma, and more. We shine a spotlight on the latest news and innovations from both our partners and community.

All posts

Subscribe to the BioVox newsletter